On the #blog: AACR President-Elect Dr. Elizabeth Jaffee predicts that this year we will see approval of anti-PD1/PDL1 and anti-CTLA4 antibody therapeutics #2018
“One of the most compelling ‘big things’ emerging in the current research landscape is the use of single-cell technologies,” Read more on Precision Medicine Advances in 2018 on the blog:
Experts Forecast Cancer Research and Treatment Advances in 2018 - #CANCER RESEARCH Catalyst #mmsm